Original Research
Published on 06 Aug 2020
Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer
in Computational Genomics
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2020.00930
- 6,822 views
- 23 citations
